Report : A-Z HCD items in Formulary 19/03/2026 17:55:20

[Back]

Section Status HCD Name 10.01.03 Restricted Use Abatacept Orencia® 01.05.03 Restricted Use Adalimumab Humira® 10.01.03 Restricted Use Adalimumab  11.99.99.99 Formulary Adalimumab Humira® 13.05.03 Formulary Adalimumab  08.01.05 Formulary Afatinib Giotrif® 11.08.02 Restricted Use Aflibercept Eylea® 08.02.03 Formulary Alemtuzumab Lemtrada® 06.06.02 Formulary Alendronic acid Binosto® 13.10.02 Formulary Amorolfine 5%  10.01.03 Restricted Use Anakinra Kineret® 13.05.03 Formulary Apremilast   08.02.03 Formulary Atezolizumab Tecentriq® 08.02.03 Formulary Avelumab Bavencio® 01.05.01 Formulary Balsalazide Sodium Colazide ® 10.01.03 Formulary Baricitinib Olumiant® 08.02.03 Formulary Blinatumomab Blincyto® 08.01.05 Formulary Bosutinib Bosulif® 08.01.05 Restricted Use Cabazitaxel Jevtana® 08.01.05 Formulary Cabozantinib Cabometyx® 10.03.02 Formulary Capsaicin cream 0.025%  08.01.05 Restricted Use Carfilzomib Kyprolis® 08.01.05 Formulary Ceritinib Zykadia® 10.01.03 Restricted Use Certolizumab Pegol Cimzia® 08.02.04 Formulary Cladribine Mavenclad® 10.03.01 Formulary Collagenase clostridium histolyticum Xiapex® 08.01.05 Formulary Crizotinib Xalkori® 08.01.05 Formulary Dasatinib Sprycel® A5.05.03 Formulary Debrisoft®  08.03.04.02 Formulary Degarelix  11.04.01 Restricted Use Dexamethasone 700mcg  Ozurdex® 13.08.01 Formulary Diclofenac 3% gel Solaraze® 08.03.01 Formulary Diethylstilbestrol  13.05.03 Formulary Dimethyl fumarate Skilarence® 08.01.05 Restricted Use Docetaxel Taxotere® 09.08.01 Formulary Eliglustat Cerdelga® 08.01.05 Formulary Eribulin Halaven® 08.01.05 Formulary Erlotinib Tarceva® 10.01.03 Restricted Use Etanercept Enbrel® 13.05.03 Formulary Etanercept  08.01.05 Formulary Everolimus Afinitor® 02.06.02 Formulary Felodipine  13.04 Formulary Flucinolone Acetonide 0.025% Synalar® Gel 13.04 Formulary Fludroxycortide tape Previously known as Haelan® 11.03.01 Formulary Fusidic acid  05.03.03.02 Formulary Glecaprevir-pibrentasvir Maviret® 13.12 Formulary Glycopyrronium  01.05 Restricted Use Golimumab Simponi® 10.01.03 Restricted Use Golimumab Simponi® 08.01.05 Formulary Ibrutinib Imbruvica® 08.01.05 Formulary Idelalisib Zydelig® 08.01.05 Formulary Imatinib Glivec® 13.08.01 Formulary Imiquimod 3.75% Zyclara® 01.05.03 Restricted Use Infliximab Remicade® 10.01.03 Restricted Use Infliximab  13.10.02 Formulary Ketoconazole 2% cream  08.01.05 Formulary Lenvatinib Kisplyx® 11.03.01 Formulary Levofloxacin Oftaquix® 01.05 Formulary Mesalazine  06.01.02.02 Formulary Metformin  08.01.05 Formulary Midostaurin Rydapt® 08.02.01 Formulary Mycophenolate Mofetil   10.02.01 Formulary Mycophenolate mofetil  03.11 Formulary Nintedanib Vargatef® 08.02.03 Formulary Nivolumab Opdivo® 08.02.03 Formulary Obinutuzumab Gazyvaro® 08.02.03 Formulary Ofatumumab Arzerra® 08.01.05 Formulary Olaparib Lynparza® 11.04.02 Formulary Olopatadine Opatanol® 01.03.05 Formulary Omeprazole Dispersible tablets  08.01.05 Formulary Osimertinib  07.04.02 Formulary Oxybutynin  08.01.05 Restricted Use Paclitaxel albumin-bound Abraxane® 08.01.05 Formulary Palbociclib Ibrance® 08.01.05 Formulary Panobinostat Farydak® 08.01.05 Formulary Pegaspargase Oncaspar® 08.01.05 Formulary Pembrolizumab Keytruda® 08.01.05 Formulary Pertuzumab Perjeta® 08.01.05 Formulary Ponatinib Iclusig® 16.01 Formulary Radium-223 Xofigo® 16.01 Formulary Radium-223 Xofigosup>® 16.06 Formulary Radium-223 Xofigo® 11.08.02 Restricted Use Ranibizumab Lucentis® 01.03.01 Formulary Ranitidine  08.01.05 Formulary Regorafenib Stivarga® 08.01.05 Formulary Ribociclib Kisqali® 10.01.03 Restricted Use Rituximab (rheumatology) MabThera® 13.05.03 Formulary Secukinumab Cosentyx® 08.01.05 Formulary Talimogene Iaherparepvec Imlygic® 06.06 Formulary Teriparatide  10.01.03 Restricted Use Tocilizumab RoActemra® 07.04.02 Formulary Tolterodine  04.07.02 Formulary Tramadol  01.05 Restricted Use Ustekinumab Stelara® 13.05.03 Formulary Ustekinumab  01.05.03 Restricted Use Vedolizumab Entyvio® 08.01.05 Formulary Vemurafenib Zelboraf® 08.01.05 Formulary Venetoclax Venclyxto®